share_log

Short Interest in Coliseum Acquisition Corp. (NASDAQ:MITA) Drops By 29.0%

Short Interest in Coliseum Acquisition Corp. (NASDAQ:MITA) Drops By 29.0%

空頭股數收購公司(納斯達克:MITA)股價下跌29.0%
Defense World ·  2022/07/31 15:41

Coliseum Acquisition Corp. (NASDAQ:MITA – Get Rating) was the target of a significant decline in short interest in July. As of July 15th, there was short interest totalling 7,600 shares, a decline of 29.0% from the June 30th total of 10,700 shares. Currently, 0.1% of the company's stock are sold short. Based on an average daily trading volume, of 29,200 shares, the days-to-cover ratio is presently 0.3 days.

競技場收購公司(納斯達克:MITA-GET評級)是空頭股數7月份大幅下跌的目標。截至7月15日,空頭股數共有7,600股,較6月30日的10,700股下跌29.0%。目前,該公司0.1%的股票被賣空。以日均成交量29,200股計算,目前天數與回補比率為0.3天。

Institutional Inflows and Outflows

機構資金流入和流出

Institutional investors and hedge funds have recently modified their holdings of the business. Exos Asset Management LLC purchased a new position in shares of Coliseum Acquisition during the fourth quarter valued at $389,000. Cantor Fitzgerald L. P. acquired a new stake in Coliseum Acquisition during the first quarter valued at $970,000. Basso Capital Management L.P. boosted its position in Coliseum Acquisition by 33.4% during the first quarter. Basso Capital Management L.P. now owns 199,750 shares of the company's stock valued at $1,938,000 after purchasing an additional 50,000 shares during the last quarter. Finally, Apollo Management Holdings L.P. boosted its position in Coliseum Acquisition by 50.0% during the fourth quarter. Apollo Management Holdings L.P. now owns 1,485,000 shares of the company's stock valued at $14,434,000 after purchasing an additional 495,000 shares during the last quarter. Hedge funds and other institutional investors own 58.98% of the company's stock.

機構投資者和對衝基金最近調整了對該公司的持股。EXOS Asset Management LLC在第四季度購買了Coliseum收購的新股份,價值38.9萬美元。Cantor Fitzgerald L.P.在第一季度收購了Coliseum的新股份,價值97萬美元。Basso Capital Management L.P.在第一季度將其在Coliseum收購中的頭寸提高了33.4%。Basso Capital Management L.P.在上個季度又購買了50,000股後,現在擁有199,750股該公司股票,價值1,938,000美元。最後,Apollo Management Holdings L.P.在第四季度將其在Coliseum收購中的頭寸提高了50.0%。阿波羅管理控股有限公司在上個季度增持了495,000股後,現在持有1,485,000股該公司股票,價值14,434,000美元。對衝基金和其他機構投資者持有該公司58.98%的股票。

Get
到達
Coliseum Acquisition
競技場收購
alerts:
警報:

Coliseum Acquisition Stock Performance

體育館收購股票表現

Shares of MITA stock opened at $9.76 on Friday. Coliseum Acquisition has a 1-year low of $9.50 and a 1-year high of $10.30. The stock's fifty day simple moving average is $9.73 and its 200-day simple moving average is $9.71.

MITA股票週五開盤報9.76美元。Coliseum收購的一年低點為9.50美元,一年高位為10.30美元。該股的50日簡單移動均線為9.73美元,200日簡單移動均線為9.71美元。

Coliseum Acquisition Company Profile

Coliseum收購公司簡介

(Get Rating)
(獲取評級)

Coliseum Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2021 and is based in New York, New York.

Coliseum Acquisition Corp.的業務規模不大。它側重於與一個或多個企業進行合併、換股、資產收購、股份購買、重組或類似的企業合併。該公司成立於2021年,總部設在紐約。

Featured Stories

專題報道

  • Get a free copy of the StockNews.com research report on Coliseum Acquisition (MITA)
  • Procter's Earnings Start To Show Weakness In Q4
  • MarketBeat: Week in Review 7/25 – 7/29
  • The One Question You Have to Ask Before Investing in INTC Stock
  • Home Depot: A Beautiful Boring Stock to Navigate a Bear Market
  • Could CRISPR Therapeutics be a Moonshot Hiding in Plain Sight?
  • 免費獲取StockNews.com關於體育館收購的研究報告(MITA)
  • 寶潔第四季度收益開始疲軟
  • MarketBeat:回顧一週7/25-7/29
  • 在投資INTC股票之前,你必須問一個問題
  • 家得寶:引領熊市的美麗而乏味的股票
  • CRISPR治療公司可能是隱藏在平坦視線中的登月計劃嗎?

Receive News & Ratings for Coliseum Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coliseum Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.

每天收到體育館收購的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Coliseum收購和相關公司的最新新聞和分析師評級的每日簡要摘要。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論